# DIFLUPREDNATE
> **ANDA211526** · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL · Approved 2021-11-17
## Drug
- **FDA Application Number:** ANDA211526
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DIFLUPREDNATE
- **Generic name:** DIFLUPREDNATE OPHTHALMIC
- **Active ingredients:** DIFLUPREDNATE
- **Dosage form:** EMULSION
- **Route:** OPHTHALMIC
- **Marketing status:** Prescription
- **Sponsor:** AMNEAL
- **Manufacturer:** Amneal Pharmaceuticals NY LLC
- **First approval:** 2021-11-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211526)
---
*AI Analytics · CC0 1.0*